Related references
Note: Only part of the references are listed.Meta-analysis of the Association Between Variants in SORL1 and Alzheimer Disease
Christiane Reitz et al.
ARCHIVES OF NEUROLOGY (2011)
Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels
Francisco Campos et al.
CLINICAL SCIENCE (2011)
Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease
Josef Marksteiner et al.
NEUROBIOLOGY OF AGING (2011)
Differences in Abundances of Cell-Signalling Proteins in Blood Reveal Novel Biomarkers for Early Detection Of Clinical Alzheimer's Disease
Mateus Rocha de Paula et al.
PLOS ONE (2011)
Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
Rebecca Craig-Schapiro et al.
PLOS ONE (2011)
A Blood-Based Screening Tool for Alzheimer's Disease That Spans Serum and Plasma: Findings from TARC and ADNI
Sid E. O'Bryant et al.
PLOS ONE (2011)
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
Joseph M. Castellano et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease
William T. Hu et al.
ACTA NEUROPATHOLOGICA (2010)
Worldwide Allele Frequencies of the Human Apolipoprotein E Gene: Climate, Local Adaptations, and Evolutionary History
Dan T. A. Eisenberg et al.
AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY (2010)
APOE Predicts Amyloid-Beta but Not Tau Alzheimer Pathology in Cognitively Normal Aging
John C. Morris et al.
ANNALS OF NEUROLOGY (2010)
Apolipoprotein E genotype is associated with serum C-reactive protein but not abdominal aortic aneurysm
Jonathan Golledge et al.
ATHEROSCLEROSIS (2010)
Biomarkers of inflammation and amyloid-beta phagocytosis in patients at risk of Alzheimer disease
Milan Fiala et al.
EXPERIMENTAL GERONTOLOGY (2010)
APOE polymorphism and its effect on plasma C-reactive protein levels in a large general population sample
Jaroslav A. Hubacek et al.
HUMAN IMMUNOLOGY (2010)
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Harald Hampel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Uncovering Molecular Biomarkers That Correlate Cognitive Decline with the Changes of Hippocampus' Gene Expression Profiles in Alzheimer's Disease
Martin Gomez Ravetti et al.
PLOS ONE (2010)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels
Holly D. Soares et al.
BIOMARKERS IN BRAIN DISEASE (2009)
Relationship of the ApoE polymorphism to plasma lipid traits among South Asians, Chinese, and Europeans living in Canada
Debika Burman et al.
ATHEROSCLEROSIS (2009)
Critical Issues for Successful Immunotherapy in Alzheimer's Disease: Development of Biomarkers and Methods for Early Detection and Intervention
Rawan Tarawneh et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Niklas Mattsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
Eric M. Reiman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Identification of a 5-Protein Biomarker Molecular Signature for Predicting Alzheimer's Disease
Martin Gomez Ravetti et al.
PLOS ONE (2008)
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Sandip Ray et al.
NATURE MEDICINE (2007)
Benchmarking a memetic algorithm for ordering microarray data
P. Moscato et al.
BIOSYSTEMS (2007)
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Ekaterina Rogaeva et al.
NATURE GENETICS (2007)
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Lars Bertram et al.
NATURE GENETICS (2007)
Proteome-based plasma biomarkers for Alzheimer's disease
A. Hye et al.
BRAIN (2006)
Apolipoprotein E ε4 and change in cognitive functioning in community-dwelling older adults
GE Swan et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2005)
Association of apolipoprotein E polymorphism with blood lipids and maximal oxygen uptake in the sedentary state and after exercise training in the HERITAGE Family Study
AS Leon et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele
RJ Caselli et al.
NEUROLOGY (2004)
Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease
P Tiraboschi et al.
NEUROLOGY (2004)
The apolipoprotein E ε4 allele and decline in different cognitive systems during a 6-year period
RS Wilson et al.
ARCHIVES OF NEUROLOGY (2002)
Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review
JE Eichner et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Assessing the accuracy of prediction algorithms for classification: an overview
P Baldi et al.
BIOINFORMATICS (2000)